利奈唑胺在小儿重症革兰阳性菌感染42例的临床应用分析(2)
参考文献:
[1]张琴.对ICU患者呼吸系统医院感染的干预研究[J].中华医院感染学杂志,2009,19(18):2407-2409.
[2]郑建铭,张永信.利奈唑胺治疗革兰阳性球菌感染的定位[J].国外医药抗生素分册,2008,29(5):201-205.
[3] Jones RN, Frit scheT R, Sader H S, et al . Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries [ J] . Diagn Microbiol Infect Dis , 2007,59( 2) : 199-209.
[4]保勇,喻华,杨永长.利奈唑胺对革兰阳性球菌的体外抗菌活性研[J].实验与检验医学,2009,27(1):23-32.
[5] Huan g YT, Liao CH , Teng LJ, et al . Comparative bactericidal activities of daptomycin, glycopeptides , linezolid and tigecycline against blood isolates of Gram-positive bacteria in Tai wan[ J ] . Clin Microbiol Infect , 2008, 14(2) :124-129.
[6] Wunderin k RG, Rello J, Cam marat a SK, et al. Linezolid vs vancomycin : Analysis of two double-blind studies of patients with methicillin-resistant Staph ylococcus aureus nosocomial pneumonia[ J ] . Chest , 2003, 124 ( 5) : 1789-1797.
[7] Bishop E,Melvani S,Howden BP,et al.Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections:a proposed protocol for monitoring therapy in complex patients [J].Antimicrob Agents Chemother,2006,50(4):1599-1602., 百拇医药(艾比拜 茹克燕.吐尔地 多力坤)
[1]张琴.对ICU患者呼吸系统医院感染的干预研究[J].中华医院感染学杂志,2009,19(18):2407-2409.
[2]郑建铭,张永信.利奈唑胺治疗革兰阳性球菌感染的定位[J].国外医药抗生素分册,2008,29(5):201-205.
[3] Jones RN, Frit scheT R, Sader H S, et al . Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries [ J] . Diagn Microbiol Infect Dis , 2007,59( 2) : 199-209.
[4]保勇,喻华,杨永长.利奈唑胺对革兰阳性球菌的体外抗菌活性研[J].实验与检验医学,2009,27(1):23-32.
[5] Huan g YT, Liao CH , Teng LJ, et al . Comparative bactericidal activities of daptomycin, glycopeptides , linezolid and tigecycline against blood isolates of Gram-positive bacteria in Tai wan[ J ] . Clin Microbiol Infect , 2008, 14(2) :124-129.
[6] Wunderin k RG, Rello J, Cam marat a SK, et al. Linezolid vs vancomycin : Analysis of two double-blind studies of patients with methicillin-resistant Staph ylococcus aureus nosocomial pneumonia[ J ] . Chest , 2003, 124 ( 5) : 1789-1797.
[7] Bishop E,Melvani S,Howden BP,et al.Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections:a proposed protocol for monitoring therapy in complex patients [J].Antimicrob Agents Chemother,2006,50(4):1599-1602., 百拇医药(艾比拜 茹克燕.吐尔地 多力坤)